Acute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon. (Record no. 1701310)

MARC details
000 -LEADER
fixed length control field 01371 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511201035.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199008s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0160-2446
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00005344-199006000-00003
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Brouwer, R M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19900816
245 00 - TITLE STATEMENT
Title Acute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of cardiovascular pharmacology
Date of publication, distribution, etc. Jun 1990
300 ## - PHYSICAL DESCRIPTION
Extent 868-76 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Gas Monitoring, Transcutaneous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fingers
General subdivision blood supply
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ketanserin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lasers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxygen
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phentolamine
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Plethysmography
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prazosin
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Raynaud Disease
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Regional Blood Flow
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Temperature
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wenting, G J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schalekamp, M A
773 0# - HOST ITEM ENTRY
Title Journal of cardiovascular pharmacology
Related parts vol. 15
-- no. 6
-- p. 868-76
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00005344-199006000-00003">https://doi.org/10.1097/00005344-199006000-00003</a>
Public note Available from publisher's website

No items available.